Popular Ayrshire restaurant opens second outlet in Kilmarnock
A popular Ayrshire restaurant has expanded its offering after opening a second outlet this week.
The team behind the award-winning Kohinoor in Largs have been working behind the scenes on a new restaurant and takeaway in Kilmarnock which officially opened its doors on Tuesday.
Customers were given the chance to sample their traditional Indian cuisine ahead of the opening through the takeaway service which began last week.
A slight delay in obtaining a bar licence meant the restaurant opened a littler later than hoped and, until today, Thursday, it will be operating a bring your own bottle policy until full service can begin.
Based on Titchfield Street in the town centre, the new venue will offer much the same quality food that their Largs regulars have become accustom to.
The frim has taken over the former Dragon Royale which moved to their new La Dragon home on St Marnock Place a number of years ago.
Following Dragon Royale moving out, the venue was left empty for years before briefly becoming the Shere Khan restaurant.
Updating customers ahead of the opening, the team behind Kohinoor said: "Firstly, we want to say a big thank you to all of you for your amazing support and patience. We know many of you are excited and eagerly waiting for us to open for sit-in dining, and we truly appreciate it.
"We believe in being transparent with our valued customers, so we wanted to let you know the reason for the delay — we are currently waiting for our bar licence to come through. This is the final step, and as soon as it's approved, we'll be ready to welcome you for full sit-in service.
"To everyone who entered our Opening Night Competition — thank you for the incredible engagement. We're running it for just a little while longer and winners will be selected very soon. Keep an eye on your messages for details and instructions.
"Once again, we appreciate your continued support, and we look forward to seeing many of you this week."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
2 days ago
- South Wales Argus
Cwmbran: Tandoorz takeaway awarded five-star hygiene rating
Tandoorz, located in Fairwater Square, opened on June 5 and was inspected on June 25. The takeaway, which serves kebabs, wraps, curries, and Indian-flavoured pizzas, was rated as "good" in both hygienic food handling and cleanliness and condition of facilities and building. In their management of food safety, they received a "very good" rating. A spokesperson for Tandoorz said: "We had our first visit from Torfaen environmental health, and we are delighted to have achieved a five-star rating. "Many thanks to all our already growing loyal customers for your support, and great thanks to the Tandoorz team. "Our kitchen is open plan, so everyone is welcome to come and see their meals being cooked fresh in front of them by our skilled chefs. "We also have lots of collection-only deals." Tandoorz offer a variety of dishes including donner kebabs in plain, tandoori, or naga flavours, and chicken tikka kebabs made from fresh marinated chicken breast cooked on the chargrill. All their kebabs and wraps are served using fresh naan cooked in the tandoor oven. They also offer traditional curries and Indian-flavoured pizzas. Customers have the option to order online at where they can get 10 per cent off and collect loyalty points. The food hygiene rating is based on three areas: hygienic food handling, cleanliness and condition of facilities and building, and management of food safety. The rating ranges from 0, which means urgent improvement is required, to 5, which means hygiene standards are very good. The inspection is carried out by officers from the food safety team at the council.
ITV News
2 days ago
- ITV News
UK-India trade deal sparks fears over access to cheap medicines for millions
A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...
Reuters
3 days ago
- Reuters
India-UK trade deal signals Modi's priorities as New Delhi eyes EU, US pacts
NEW DELHI, July 25 (Reuters) - India's trade deal with Britain is a sign of New Delhi's new gradual shift to opening up its markets while shielding crucial sectors from competition and could be its template for future agreements, government officials and analysts said on Friday. Signed on Thursday and hailed by Prime Minister Narendra Modi as "a blueprint for our shared prosperity", the deal with the UK represents India's biggest ever strategic partnership with an advanced economy. It comes at a time rising global trade tensions and at a pivotal moment for India's historically protectionist trade strategy, as the Asian giant looks to strike similar deals with partners including the EU, U.S., and New Zealand. Under the pact, India notably agreed to cut tariffs on imported British vehicles, opening up competition for a domestic industry that makes up nearly 7% of the Indian economy. "This is a policy shift, especially as India has long used high tariffs to protect domestic manufacturers," Ajay Srivastava, founder of Global Trade Research Initiative and a former Indian trade negotiator, told Reuters. The easing of its protectionist stance also applies to government procurement and pharmaceuticals and will likely be replicated in deals with Brussels and Washington, he added. But it remains a cautious shift. Under the UK deal, auto imports will be capped under a quota system to shield local manufacturers, and tariff reductions will be gradual. India has committed to reducing auto tariffs from over 100% to 10% over 15 years, within an annual import quota starting at 10,000 units and rising to 19,000 in year five. Tariff reductions on whisky and other goods will also be phased over several years to allow domestic industries to adjust. India has stuck to its red lines in the deal, making no concessions on agricultural items such as apples and walnuts or dairy products including cheese and whey. "There is no question of opening up the agriculture or dairy sector in any trade negotiation — be it with the EU, Australia, or even the U.S.," a senior Indian official said. The calibrated strategy aims to leverage trade for economic growth, the official said, but the government will continue to shield millions of Indians dependent upon subsistence farming and low-margin work. Indian farmers are eyeing broadened access to the UK's $37.5 billion agriculture market under the deal. And Indian exporters will benefit from zero tariffs on goods including textiles, footwear, gems, furniture, auto parts, machinery, and chemicals. "With zero tariffs, India's garment exports to the UK could double in three years," said N. Thirukkumaran, general secretary of the Tiruppur Exporters Association. "This also paves the way for the EU agreement, which could bring even bigger gains," he added. But the strategy could face a major test in negotiations with U.S. President Donald Trump's administration, which has used the threat of steep tariffs to pressure trading partners into making concessions. Trade Minister Piyush Goyal told Reuters on Thursday that India is also hopeful of reaching a trade agreement with Washington that includes "special and preferred treatment". But the U.S. is pushing for greater access to India's agricultural and dairy markets.
